Increased blood-brain barrier permeability in neuro-asymptomatic HIV infected individuals—correlation with cerebrospinal fluid HIV-1 RNA and neopterin levels

References

• An SF, Groves M, Giometto B, Beckett AA, Scaravilli F (1999). Detection and localisation of HIV-1 DNA and RNA in fixed adult AIDS brain by polymerase chain reaction/in situ hybridisation technique. Acta Neu-ropathol (Berl) 98: 481–487.
   PubMed Web of Science ®Google Scholar
• Andersson L, Blennow K, Fuchs D, Svennerholm B, Gisslen M (1999). Increased cerebrospinal fluid protein tau con-centration in neuro-AIDS. I Neurol Sci 171: 92–96.
   Google Scholar
• Andersson LM, Fredman P, Lekman A, Rosengren L, Gisslen M (1998). Increased cerebrospinal fluid ganglio-side GD3 concentrations as a marker of microglial activa-tion in HIV type 1 infection. AIDS Res Hum Retroviruses 14: 1065–1069.
   Google Scholar
• Blennow K, Fredman P, Wallin A, Gottfries CG, Karlsson I, Langstrom G, Skoog I, Svennerholm L, Wikkelso C (1993). Protein analysis in cerebrospinal fluid. II. Ref-erence values derived from healthy individuals 18–88 years of age. Eur Neurol 33: 129–133.
   Google Scholar
• Boven LA, Middel J, Verhoef J, De Groot CJ, Nottet HS (2000). Monocyte infiltration is highly associated with loss of the tight junction protein zonula occludens in HIV-1-associated dementia.Neuropathol App] Neuro-biol 26: 356–360.
   Google Scholar
• Brew BJ, Dunbar N, Pemberton L, Kaldor J (1996). Pre-dictive markers of AIDS dementia complex: CD4 cell count and cerebrospinal fluid concentrations of beta 2-microglobulin and neopterin. I Infect Dis 174: 294–298.
   PubMed Web of Science ®Google Scholar
• Brew BJ, Bhalla RB, Paul M, Gallardo H, McArthur JC, Schwartz MK, Price RW (1990). Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection. Ann Neurol 28: 556–560.
   PubMed Web of Science ®Google Scholar
• Budka H (1991). Neuropathology of human immunodefi-ciency virus infection. Brain Pathol 1: 163–175.
   PubMed Web of Science ®Google Scholar
• Chiodi F, Sonnerborg A, Albert J, Gaines H, Norkrans G, Hagberg L, Asjo B, Strannegard O, Fenyo EM (1988). Human immunodeficiency virus infection of the brain. I. Virus isolation and detection of HIV specific an-tibodies in the cerebrospinal fluid of patients with varying clinical conditions. I Neurol Sci 85: 245–257.
   Google Scholar
• Coombs RW, Henrard DR, Mehaffey WF, Gibson J, Eggert E, Quinn TC, Phillips J (1993). Cell-free plasma hu-man immunodeficiency virus type 1 titer assessed by culture and immunocapture-reverse transcription-polymerase chain reaction. I Clin Microbiol 31: 1980–1986.
   Google Scholar
• Dallasta LM, Pisarov LA, Esplen JE, Werley JV, Moses AV, Nelson JA, Achim CL (1999). Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am J Pathol 155: 1915–1927.
   Google Scholar
• Davis LE, Hj elle BL, Miller VE, Palmer DL, Llewellyn AL, Merlin TL, Young SA, Mills RG, Wachsman W, Wiley CA (1992). Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Ne urology 42: 1736–1739.
   Google Scholar
• Foudraine NA, Hoetelmans RM, Lange JM, de Wolf F, van Benthem BH, Maas JJ, Keet IP, Portegies P (1998). Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine. Lancet 351: 1547–1551.
   PubMed Web of Science ®Google Scholar
• Fuchs D, Chiodi F, Albert J, Asjo B, Hagberg L, Hausen A, Norkrans G, Reibnegger G, Werner ER, Wachter H (1989). Neopterin concentrations in cerebrospinal fluid and serum of individuals infected with HIV-1. AIDS 3: 285–288.
   PubMed Web of Science ®Google Scholar
• Furukawa Y, Nishi K, Kondo T, Tanabe K, Mizuno Y (1992). Significance of CSF total neopterin and biopterin in inflammatory neurological diseases. I Neurol Sci 111: 65–72.
   PubMed Web of Science ®Google Scholar
• Gisslen M, Fuchs D, Svennerholm B, Hagberg L (1999). Cerebrospinal fluid viral load, intrathecal immunoacti-vation, and cerebrospinal fluid monocytic cell count in HIV-1 infection. J Acquir Immune Defic Syndr 21: 271–276.
   Google Scholar
• Hagberg L, Dotevall L, Norkrans G, Larsson M, Wachter H, Fuchs D (1993). Cerebrospinal fluid neopterin concen-trations in central nervous system infection. I Infect Dis 168: 1285–1288.
   Google Scholar
• Katzenstein TL, Pedersen C, Nielsen C, Lundgren JD, Jakobsen PH, Gerstoft J (1996). Longitudinal serum HIV RNA quantification: correlation to viral phenotype at seroconversion and clinical outcome. AIDS 10: 167–173.
   PubMed Web of Science ®Google Scholar
• Kure K, Llena JF, Lyman WD, Soeiro R, Weidenheim KM, Hirano A, Dickson DW (1991). Human immunodefi-ciency virus-1 infection of the nervous system: an au-topsy study of 268 adult, pediatric, and fetalbrains. Hum Pathol 22: 700–710.
   PubMed Web of Science ®Google Scholar
• Marshall DW, Brey RL, Butzin CA, Lucey DR, Abbadessa SM, Boswell RN (1991). CSF changes in a longitudinal study of 124 neurologically normal HIV infected U.S. Air Force personnel. I Acquir Immune Defic Syndr 4: 777–781.
   Google Scholar
• Marshall DW, Brey RL, Cahill WT, Houk RW, Zajac RA, Boswell RN (1988). Spectrum of cerebrospinal fluid findings in various stages of human immunodeficiency virus infection. Arch Neurol 45: 954–958.
   PubMedGoogle Scholar
• Martin C, Albert J, Hansson P, Pehrsson P, Link H, Sonnerborg A (1998). Cerebrospinal fluid mononuclear cell counts influence CSF HIV-1 RNA levels. I Ac-quir Immune Defic Syndr Hum Retrovirol 17: 214–219.
   PubMedGoogle Scholar
• McArthur JC, McClernon DR, Cronin MF, Nance-Sproson TE, Saah AJ, St Clair M, Lanier ER (1997). Relationship between human immunodeficiency virus-associated de-mentia and viral load in cerebrospinal fluid and brain. Ann Neurol 42: 689–698.
   PubMed Web of Science ®Google Scholar
• McArthur JC, Nance-Sproson TE, Griffin DE, Hoover D, Seines OA, Miller EN, Margolick JB, Cohen BA, Farzadegan H, Saah A (1992). The diagnostic utility of elevation in cerebrospinal fluid beta 2-microglobulin in HIV-1 dementia. Multicenter AIDS Cohort Study. Neurology 42: 1707–1712.
   PubMed Web of Science ®Google Scholar
• MMWR (1992). 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMVVR Morb Mortal Wkly Rep 41: 1–19.
   Google Scholar
• Navia BA, Cho ES, Petito CK, Price RW (1986). The AIDS dementia complex: II. Neuropathology. Ann Neurol 19: 525–535.
   Google Scholar
• Persidsky Y, Zheng J, Miller D, Gendelman HE (2000). Mononuclear phagocytes mediate blood-brain bar-rier compromise and neuronal injury during HIV-1-associated dementia. J Leukoc Biol 68: 413–422.
   PubMed Web of Science ®Google Scholar
• Petito CK, Cash KS (1992). Blood-brain barrier ab-normalities in the acquired immunodeficiency syn-drome: immunohistochemical localization of serum proteins in postmortem brain. Ann Neurol 32: 658–666.
   PubMed Web of Science ®Google Scholar
• Power C, Kong PA, Crawford TO, Wesselingh S, Glass JD, McArthur JC, Trapp BD (1993). Cerebral white mat-ter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier. Ann Neurol 34: 339–350.
   PubMed Web of Science ®Google Scholar
• Schacker T, Collier AC, Hughes J, Shea T, Corey L (1996). Clinical and epidemiologic features of primary HIV in-fection. Ann Intern Med 125: 257–264.
   Google Scholar
• Sebire K, McGavin K, Land S, Middleton T, Birch C (1998). Stability of human immunodeficiency virus RNA in blood specimens as measured by a commercial PCR-based assay. I Clin Microbiol 36: 493–498.
   Google Scholar
• Sonnerborg AB, von Stedingk LV, Hansson LO, Strannegard 00 (1989). Elevated neopterin and beta 2-microglobulin levels in blood and cerebrospinal fluid occur early in HIV-1 infection. AIDS 3: 277–283.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Wesselingh SL, Griffin DE, McArthur JC, Johnson RT, Glass JD (1996). Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann Neurol 39: 705–711.
   PubMed Web of Science ®Google Scholar
• Tibbling G, Link H, Ohman S (1977). Principles of albumin and IgG analyses in neurological disorders. I. Establish-ment of reference values. Scand I Clin Lab Invest 37: 385–390.
   Google Scholar
• Trujillo JR, Garcia-Ramos G, Novak IS, Rivera VM, Huerta E, Essex M (1995). Neurologic manifestations of AIDS: a comparative study of two populations from Mexico and the United States. I Acquir Immune Defic Syndr Hum Retrovirol 8: 23–29.
   Google Scholar
• Wiley CA, Achim C (1994). Human immunodeficiency virus encephalitis is the pathological correlate of de-mentia in acquired immunodeficiency syndrome. Ann Neurol 36: 673–676.
   PubMedGoogle Scholar
• Wiley CA, MasliahE, Morey M, Lemere C, De Teresa R, Grafe M, Hansen L, Terry R (1991). Neoc ortic al damage during HIV infection. Ann Neurol 29: 651–657.
   PubMed Web of Science ®Google Scholar
• Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MB (1986). Cellular localization of human immuno-deficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Nail Acad Sci USA 83: 7089–7093.
   PubMed Web of Science ®Google Scholar